Jak stosować KORYFIN TOSSE MUKOLITIKO
Treść ulotki
CORYFIN TOSSE MUCOLITICO 250 mg/5 ml syrup
carbocisteine
Read this leaflet carefully before using this medicine as it contains important
information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or
pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- If you want more information or advice, ask your pharmacist.
- If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
- See a doctor if you do not feel better or if your symptoms worsen after 7 days for children and 14 days for adults.
Contents of this leaflet:
- 1. What CORYFIN TOSSE MUCOLITICO is and what it is used for
- 2. What you need to know before you use CORYFIN TOSSE MUCOLITICO
- 3. How to use CORYFIN TOSSE MUCOLITICO
- 4. Possible side effects
- 5. How to store CORYFIN TOSSE MUCOLITICO
- 6. Contents of the pack and other information
1. What is CORYFIN TOSSE MUCOLITICO and what is it used for
CORYFIN TOSSE MUCOLITICO contains carbocisteine, a substance that belongs to the group of
medicines called “mucolytics”. It acts, in respiratory conditions, by fluidifying the mucous secretions
of the respiratory tract. By reducing the viscosity of mucus, these medicines promote
its elimination externally.
Consult your doctor if you do not feel better or if you feel worse after 14 days, or if your child
does not feel better or feels worse after 7 days.
2. What you need to know before using CORYFIN TOSSE MUCOLITICO
Do not use CORYFIN TOSSE MUCOLITICO
- if you are allergic to the active ingredient or to any of the other ingredients of this medicine (listed in section 6);
- if you have a stomach or intestinal ulcer;
- if you are pregnant or breastfeeding;
- in children under 2 years of age.
Warnings and precautions
Consult your doctor or pharmacist before using CORYFIN TOSSE MUCOLITICO.
If the disorder occurs repeatedly or if you have noticed any recent change in its
characteristics, consult your doctor.
Caution is recommended in elderly patients, asthmatic patients with a history of severe
respiratory problems, debilitated patients, those with a history of gastroduodenal ulcers or those
who are taking drugs known to cause gastrointestinal bleeding.
You must stop treatment with carbocisteine in case of gastrointestinal bleeding.
This medicine should not be used in association with cough suppressants and/or medicines that
inhibit bronchial secretion.
Children
Do not use this medicine in children under 2 years of age, because their airways are not
yet mature and this medicine may cause an obstruction of their bronchi (bronchial
obstruction), causing difficulty breathing (see section 2 “Do not use CORYFIN TOSSE
MUCOLITICO”).
Other medicines and CORYFIN TOSSE MUCOLITICO
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicines.
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding,
ask your doctor or pharmacist for advice before taking this medicine.
This medicine should not be used during pregnancy or breastfeeding.
Driving and operating machinery
This medicine does not affect the ability to drive vehicles or operate machinery.
CORYFIN TOSSE MUCOLITICO contains:
- methyl parahydroxybenzoate:may cause allergic reactions (including delayed reactions).
- sucrose:if your doctor has diagnosed you with intolerance to certain sugars, contact him/her before taking this medicine. This medicine contains 6.3 g of sucrose per dose (15 ml). This should be taken into consideration in people affected by diabetes mellitus.
- sodium:this medicine contains 36.85 mg of sodium (the main component of table salt) per 5 ml dose and 110.55 mg of sodium per 15 ml dose. This corresponds to 1.84% and 5.53% of the maximum recommended daily intake with the diet of an adult, respectively.
3. How to use CORYFIN TOSSE MUCOLITICO
Use this medicine following exactly as indicated in this leaflet or by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
The recommended dose in adultsis 15 ml 3 times a day.
Use in children
The recommended dose in children from 2 to 5 years of ageis 5 ml 2 times a day.
The recommended dose in children from 5 to 10 years of ageis 15 ml 2 times a day.
Caution: do not exceed the indicated doses. Use only for short periods of treatment.
CORYFIN TOSSE MUCOLITICO can also be taken for prolonged periods. However, if after
2 weeks of treatment in adults and after 7 days of treatment in children, the symptoms do not
resolve, it is recommended to consult a doctor.
Instructions for use:
If you use more CORYFIN TOSSE MUCOLITICO than you should
If you have taken an excessive dose of CORYFIN TOSSE MUCOLITICO syrup, immediately notify
your doctor or go to the nearest hospital.
In case of an overdose, you may experience headache, nausea, diarrhea, or stomach pain (gastralgia).
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the following side effects occur stop treatmentand immediately inform your
doctor:
- swelling of the face and/or throat, itching, sudden drop in blood pressure (anaphylactic reaction);
- red spots or bumps (skin rash) which may be a symptom of an allergic reaction;
- appearance of rounded blisters with clear borders (fixed erythema).
If any of the following side effects occur reduce the doseor discontinue treatment:
- dizziness;
- stomach pain (upper abdominal pain), nausea, diarrhea.
With this medicine, bronchial obstruction (bronchial obstruction) may occur,
which causes difficulty breathing.
- Irritations and skin diseases (Stevens-Johnson syndrome; bullous dermatitis; erythema multiforme; toxic skin rash). In such cases, stop treatment and consult your doctor to establish appropriate therapy.
- Gastrointestinal bleeding. In such cases, stop treatment and consult your doctor to establish appropriate therapy.
Reporting of side effects
If you experience any side effects, including those not listed in this leaflet, please inform
your doctor or pharmacist. You can also report side effects directly through the
national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse.
By reporting side effects you can help provide more information on the safety
of this medicine.
5. How to store CORYFIN TOSSE MUCOLITICO
Store at a temperature below 25°C.
![]() | To open the bottle: press the cap down while unscrewing in a counterclockwise direction. c To close the bottle: screw the cap on tightly in a clockwise direction. |
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after “Exp.”. The expiry
date refers to the last day of that month.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What CORYFIN TOSSE MUCOLITICO contains
- The active ingredient is carbocisteine. 5 ml of syrup contains 250 mg of carbocisteine.
- The other components are dibasic sodium phosphate dodecahydrate, methyl parahydroxybenzoate, sucrose, raspberry essence, caramel, sodium hydroxide, purified water.
Description of the appearance of CORYFIN TOSSE MUCOLITICO and contents of the pack
CORYFIN TOSSE MUCOLITICO is presented in a dark glass bottle containing 200 ml of
syrup, with a child-resistant closure cap and graduated measuring cup.
Marketing Authorisation Holder
Laboratorio Farmaceutico SIT S.r.l. - Via Cavour, 70 – 27035 Mede (PV).
Manufacturer
Laboratorio Farmaceutico SIT S.r.l. - Via Provinciale per Lecco, 78 - 22038 Tavernerio (CO).

- Kraj rejestracji
- Postać farmaceutycznaSyrup, 250 MG/5 ML
- Kod ATCR05CB03
- Substancja czynna
- Wymaga receptyNie
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki KORYFIN TOSSE MUKOLITIKOPostać farmaceutyczna: Granules for oral solution, 2.7 GSubstancja czynna: carbocisteineProducent: IPSO PHARMA S.R.L.Wymaga receptyPostać farmaceutyczna: Granules for oral solution, 2.7 gSubstancja czynna: carbocisteineProducent: IPSO PHARMA S.R.L.Wymaga receptyPostać farmaceutyczna: Granules for oral solution, 2.7 GSubstancja czynna: carbocisteineProducent: DOMPE' FARMACEUTICI S.P.A.Bez recepty
Odpowiedniki KORYFIN TOSSE MUKOLITIKO w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik KORYFIN TOSSE MUKOLITIKO w Hiszpania
Odpowiednik KORYFIN TOSSE MUKOLITIKO w Polska
Odpowiednik KORYFIN TOSSE MUKOLITIKO w Ukraina
Lekarze online w sprawie KORYFIN TOSSE MUKOLITIKO
Omów stosowanie KORYFIN TOSSE MUKOLITIKO, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Uzyskaj receptę na KORYFIN TOSSE MUKOLITIKO online
Wypełnij 2-minutowy formularz
Opisz swoje objawy, historię choroby i lek, o który prosisz.
Wybierz lekarza lub pozwól nam przydzielić
Wybierz specjalistę lub dopasujemy Cię do najbliższego dostępnego lekarza.
Lekarz analizuje Twój przypadek
Zazwyczaj w ciągu 30 minut. Może zadawać dodatkowe pytania przez czat.
Odbierz w dowolnej aptece
Recepta elektroniczna wysłana na Twój e-mail — ważna w całej Polsce.
Często zadawane pytania
KORYFIN TOSSE MUKOLITIKO nie wymaga recepty w Włochy. Możesz skonsultować się z lekarzem online, aby sprawdzić, czy ten lek może być odpowiedni w Twojej sytuacji.
Substancją czynną w KORYFIN TOSSE MUKOLITIKO jest carbocisteine. Informacja ta pomaga rozpoznać leki o tym samym składzie, ale pod różnymi nazwami handlowymi.
KORYFIN TOSSE MUKOLITIKO jest produkowany przez LABORATORIO FARMACEUTICO SIT SPECIALITA IGIENICO TERAPEUTICHE S.R.L.. Nazwy handlowe i opakowania mogą się różnić w zależności od dystrybutora.
Lekarze, tacy jak Lekarze rodzinni, Psychiatrzy, Dermatolodzy, Kardiolodzy, Endokrynolodzy, Gastroenterolodzy, Pulmonolodzy, Nefrolodzy, Reumatolodzy, Hematolodzy, Zakaźnicy, Alergolodzy, Geriatrzy, Pediatrzy, Onkolodzy, mogą ocenić, czy stosowanie KORYFIN TOSSE MUKOLITIKO jest odpowiednie w Twoim przypadku, w zależności od sytuacji klinicznej i lokalnych przepisów. Możesz umówić konsultację online, aby omówić objawy i możliwe dalsze kroki.
Polska posiada dobrze rozwiniętą infrastrukturę ochrony zdrowia w dużych miastach, takich jak Warszawa, Kraków, Wrocław i Gdańsk. Apteki są łatwo dostępne i działają zgodnie z obowiązującymi przepisami, zapewniając dostęp do leków na receptę.
Możesz kupić KORYFIN TOSSE MUKOLITIKO w Warszawie, Krakowie, Wrocławiu lub Gdańsku w każdej aptece, posiadając ważną receptę.
Aby uzyskać receptę, możesz skorzystać z Oladoctor:
Inne leki zawierające tę samą substancję czynną (carbocisteine) to m.in. BRONKOLIB, KARBOKISTEINA IPSO PARMA, FLUIFORT. Mogą one różnić się nazwą handlową lub postacią, ale zawierają ten sam składnik terapeutyczny. Przed zmianą lub rozpoczęciem nowego leku skonsultuj się z lekarzem.

















